机构地区:[1]南京大学医学院附属鼓楼医院肝脏外科,210008 [2]南京大学医学院附属鼓楼医院药剂科,210008
出 处:《中华消化外科杂志》2017年第12期1183-1190,共8页Chinese Journal of Digestive Surgery
基 金:国家自然科学基金(81670566);江苏省科教强卫工程(ZDRCA2016066)
摘 要:目的:探讨术前营养支持(PNS)治疗在有营养风险患者行肝切除术中的临床价值。 方法:采用前瞻性研究方法。选取2012年8月至2016年6月南京大学医学院附属鼓楼医院收治的133例有营养风险行肝切除术患者的临床资料。将患者按随机数字表法分为PNS组和对照组,PNS组患者采用PNS治疗,对照组采用传统治疗。观察指标:(1)两组患者实验室检查指标比较。(2)两组患者术后情况比较。(3)两组患者术后并发症比较。正态分布的计量资料以±s表示,组间比较采用独立样本t检验,计数资料比较采用X2检验。重复测量数据采用重复测量方差分析。 结果:筛选出符合研究条件的患者133例,PNS组68例,对照组65例。(1)两组患者实验室检查指标比较:PNS组患者入院时ALT、AST、TBil、胆碱酯酶、Alb、前白蛋白、转铁蛋白、C反应蛋白分别为(36±13)U/L、(29±10)U/L、(18.5±2.4)mmol/L、(5 738±1 824)U/L、(37.4±5.1)g/L、(155±48)mg/L、(2.2±0.5)g/L、(10±4)g/L,术前分别为(33±9)U/L、(27±8)U/L、(17.9±1.8)mmol/L、(5 796±2 016)U/L、(38.5±4.7)g/L、(181±40)mg/L、(2.4±0.5)g/L、(8±4)g/L,术后第1天分别为(285±100)U/L、(218±93)U/L、(33.5±6.3)mmol/L、(4 847±1 044)U/L、(32.6±3.8)g/L、(105±34)mg/L、(1.3±0.4)g/L、(55±28)g/L,术后第3天分别为(149±84)U/L、(76±42)U/L、(22.7±4.9)mmol/L、(3 866±893)U/L、(34.2±2.4)g/L、(125±30)mg/L、(1.6±0.4)g/L、(51±34)g/L,术后第7天分别为(64±33)U/L、(44±18)U/L、(19.4±2.8)mmol/L、(4 257±1 032)U/L、(37.0±2.1)g/L、(148±42)mg/L、(1.9±0.4)g/L、(16±11)g/L;对照组患者入院时ALT、AST、TBil、胆碱酯酶、Alb、前白蛋白、转铁蛋白、C反应蛋白分别为(36±15)U/L、(31±12)U/L、(18.3±2.9)mmol/L、(5 762±Objective:To investigate the clinical value of preoperative nutritional support (PNS) therapy in the hepatectomy of patients with nutritional risk. Methods:The prospective study was conducted. The clinical data of 133 patients with nutritional risk who were admitted to the Drum Tower Hospital Affiliated to Nanjing University Medical School from August 2012 to June 2016 were collected. All the patients undergoing PNS and traditional therapy were divided into the PNS group and the control group by random number table method, respectively. Observation indicators: (1) comparisons of laboratory indexes between groups; (2) comparisons of postoperative situations between groups; (3) comparisons of postoperative complications between groups. Measurement data with normal distribution were represented as ±s. Comparisons between groups were evaluated with the independent-sample t test. Comparisons of count data were analyzed using the chi-square test, and repeated measures data were analyzed by the repeated measures ANOVA. Results:All the 133 patients were screened for eligibility, including 68 in the PNS group and 65 in the control group. (1) Comparisons of laboratory indexes between groups: alanine transaminase (ALT), aspartate transaminase (AST), total bilirubin (TBil), cholinesterase, albumin (Alb), prealbumin, transferrin and C-reactive protein (CRP) in the PNS group were respectively (36±13)U/L, (29±10)U/L, (18.5±2.4)mmol/L, (5 738±1 824)U/L, (37.4±5.1)g/L, (155±48)mg/L, (2.2±0.5)g/L, (10±4)g/L at admission and (33±9)U/L, (27±8)U/L, (17.9±1.8)mmol/L, (5 796±2 016)U/L, (38.5±4.7)g/L, (181±40)mg/L, (2.4±0.5)g/L, (8±4)g/L before operation and (285±100)U/L, (218±93)U/L, (33.5±6.3)mmol/L, (4 847±1 044)U/L, (32.6±3.8)g/L, (105±34)mg/L, (1.3±0.4)g/L, (55±28)g/L at 1 day postoperatively and (149±84)U/L, (76±42)U/L, (22.7±4.9)mmol/L, (3 8
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...